CWM
ENZN

Concert Wealth Management’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Concert Wealth Management’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-45,939
Closed -$21K – 754
2016
Q1 		$21K Buy
45,939
+1
+0% – ﹤0.01% 668
2015
Q4 		$30K Sell
45,938
-1
-0% -$1 ﹤0.01% 674
2015
Q3 		$45K Buy
45,939
+7,409
+19% +$9.12K 0.01% 689
2015
Q2 		$46K Buy
+38,530
New +$49.1K 0.01% 686

Other funds holding ENZN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
MCM
Monarch Capital Management Fort Wayne, Indiana $436M AUM 26.61% 1-Year Est. Return
CFA
CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return

Concert Wealth Management's ENZN Position: Q2 2016 in Review

Concert Wealth Management sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q2 2016, closing a stake of 45,939 shares — an estimated $21K sold.

Concert Wealth Management first reported a position in ENZN in Q2 2015 and held it in 4 quarters. The position peaked at $46K in Q2 2015. 10 funds tracked by Wall St. Rank hold ENZN as of Q2 2016.

  • Concert Wealth Management reported no remaining ENZON PHARMACEUTICALS INC position as of Q2 2016 after selling out during the quarter.
  • Concert Wealth Management sold 45,939 ENZON PHARMACEUTICALS INC shares in Q2 2016, an estimated $21K.
  • Concert Wealth Management first reported a position in ENZON PHARMACEUTICALS INC in Q2 2015 and held it in 4 quarters.
  • Concert Wealth Management's ENZON PHARMACEUTICALS INC position peaked at $46K in Q2 2015.
  • 10 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q2 2016.

Based on Concert Wealth Management's 13F filing for Q2 2016, filed 28 Jul 2016.